Literature DB >> 10354170

Isoniazid induced pellagra despite pyridoxine supplementation.

A Darvay1, T Basarab, J M McGregor, R Russell-Jones.   

Abstract

Although pellagra is a recognized complication of isoniazid therapy, the diagnosis may be overlooked or delayed--sometimes with life-threatening consequences. We report a case of isoniazid-induced pellagra which occurred despite pyridoxine supplementation. Drug withdrawal and supplementation with niacin led to a rapid and sustained clinical improvement. The possible mechanisms of isoniazid induced pellagra are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354170     DOI: 10.1046/j.1365-2230.1999.00444.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

1.  An Outbreak of Pellagra in the Kasese Catchment Area, Dowa, Malawi.

Authors:  George Matapandeu; Samuel H Dunn; Patti Pagels
Journal:  Am J Trop Med Hyg       Date:  2017-05-13       Impact factor: 2.345

2.  Case report--A forgotten dermatological disease.

Authors:  D Segula; P Banda; C Mulambia; J J Kumwenda
Journal:  Malawi Med J       Date:  2012-03       Impact factor: 0.875

3.  A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct.

Authors:  Sebabrata Mahapatra; Lisa K Woolhiser; Anne J Lenaerts; John L Johnson; Kathleen D Eisenach; Moses L Joloba; W Henry Boom; John T Belisle
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

Review 4.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Pellagra in isoniazid preventive and antiretroviral therapy.

Authors:  John Koech Kipsang; Joseph K Choge; Pamela A Marinda; Christopher Khayeka-Wandabwa
Journal:  IDCases       Date:  2019-05-03

6.  Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy.

Authors:  Sarah J Coates; Amy W Blasini; Patrick Musinguzi; Miriam Laker-Oketta
Journal:  IDCases       Date:  2020-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.